retatrutide release date FDA Approval Status 2026: Everything We Know So Far Who Makes Retatrutide? Company Behind

Seven additional Phase 3 trials for retatrutide are expected to report results in 2026

Side effect tracking is a requirement for anyone on these medications

There's not a surge in rates of Obesity or Type 2 Diabetes, and nearly 15% of its population is uninsured

Thus, it is feasible that even if there may be a tumor-promoting effect that the duration of drug exposure may not be sufficient to significantly increase the risk of tumorigenesis

10.3390/antiox13101246 50 MaH.HuangW.WangX.ZhaoL.JiangY.LiuF.et al (2020)

These findings suggest that low doses can still be effective, especially when paired with lifestyle changes like diet and exercise